Back to search

University of Crete (UOC)

Κλινικοεπιδημιολογική μελέτη και έλεγχος της πολυαντοχής των βακτηριδίων στο Πανεπιστημιακό Γενικό Νοσοκομείο Ηρακλείου

Abstract

dc:description

Study 1: Antimicrobial resistance and antibiotic consumption in the UniversityHospital of HeraklionObjective: to study the most common isolates, their main resistance patterns, theconsumption of antibiotics, as well as related timely trends in the university hospital ofHeraklion.Methods: During a 15-month period (January 2009 through March 2010), microorganismsisolated in the hospital per sample and their respective resistance patterns were recordedon a daily basis. Aggregate data concerning antibiotic consumption were analyzed for twodifferent time periods, 2004-06 and 2008-09. Antibiotic consumption was classifiedaccording to the J01 group of the Anatomical Therapeutic Chemical 2006 of the WorldHealth Organization. Results were compared to other studies from the literature.Results: 6364 non duplicate isolates were recorded and 4705 (73.9%) were nosocomial, ofwhich 39.1% were isolated in medical departments, 26.6% in surgical departments, 17.8%in the ICU and 16.5% in pediatric departments. The most commonly isolatedmicroorganisms were coagulase-negative staphylococci (CNS, 18.4% of total), E. coli(16.0%), Enterococcus spp (11.1%), K. pneumoniae (8.5%) and P. aeruginosa (7.4%). CNS were the most common microorganisms in blood cultures (46.6% of positive bloodcultures), E. coli was the most common microorganism cultured from urine (54.4%), andfrom the lower respiratory tract the most common isolates were A. baumannii (19.9%), P.aeruginosa (13.5%), K. pneumoniae (11.1%) and S. aureus (10.6%). Compared to previous years, most resistance rates were similar or decreasing, with the exclusion of K.pneumoniae isolates which presented a clear increase in resistance to all tested antibiotics(56.7% production of ESBL, 42.2% resistance to imipenem, 51.7% to fluoroquinolones,7.1% to colistin). Increasing resistance to fluoroquinolones was also observed among E.coli isolates, whereas A. baumannii were overall resistant to carbapenems (82.9%), withisolates from the ICU, Internal Medicine, Hematology, Nephrology and Neurosurgerydepartments being increasingly resistant compared to previous years. Resistance patternsof P. aeruginosa were steady compared to previous years (19.8% to imipenem, 12.4% tofluoroquinolones, 7.2% to gentamicin) and similar to rates presented in the literature.Resistance rates of gram-positive microrganisms, particularly vancomycin-resistantenterococci (5%),, methicillin-resistant S. aureus (39.1%) and methicillin-resistant CNS(66.1%), were lower in 2009 compared to previous years and were also similar or lowerthan rates reported in the literature. In the ICU, the most common blood isolates were CNS(isolated in 53.7% of blood cultures), while A. baumannii (25.6%) and K. pneumoniae(13.2%) prevailed in lower respiratory tract samples. High resistance rates were observedamong K. pneumoniae and A. baumannii isolates, whereas resistance rates of staphylococci,enterococci, E. coli and P. aeruginosa were similar or lower compared to the literature.Concerning antibiotic consumption, cephalosporins were the most commonlyprescribed antibiotics in the hospital (20% of total consumption,), followed byfluoroquinolones (15%) and b-lactam/inhibitor combinations (13%). Total antibioticconsumption had a 73% increase in 2009 compared to 1998 and mainly involvedextended spectrum antibiotic groups. Compared to most studies, there is similar or lowerconsumption of b-lactams, but a significantly higher consumption of cephalosporins,carbapenems and new antibiotics such as macrolides, fluoroquinolones, glycopeptides,linezolid, polymyxins, daptomycin and tigecycline. Total antibiotic consumption in the ICUwas significantly higher compared to the hospital overall and the literature.Conclusions: this study highlights the most important areas for improvement: highresistance rates among the most commonly isolated gram-negative microorganisms andan increasing consumption of extended spectrum and of novel, last resort antibiotics,accompanied by a decrease in consumption of narrow-spectrum antibiotics. In the ICU,enhancement of infection control interventions, as well as antimicrobial stewardship arerequired due to high resistance rates among K. pneumoniae and A. baumannii isolates andincreased antibiotic consumption.Study 2: Infections by pandrug-resistant gram-negative bacteria: clinical profile, therapeutic management, and outcome in a series of 21 patientsObjective: to describe and analyze the clinical characteristics, therapeutic management andoutcome of infections due to pandrug-resistant (PDR) gram-negative bacteria whichoccurred over a 2-year period in the University Hospital of Heraklion.Methods: observational case series study of infections due to PDR gram-negative bacteriafrom April 2006 through April 2008 in the university hospital of Heraklion. Isolated A.baumannii, K. pneumoniae and P. aeruginosa strains were considered PDR if they wereresistant to all classes of antibiotics used for empirical treatment.Results: A total of 21 patients infected by 23 PDR gram-negative bacteria were recorded.The mean APACHE II score on admission was 18.8, the mean Charlson comorbidity indexwas 2.9, and 20 (95.2%) patients had previous ICU hospitalization. All patients had recentexposure to multiple antibiotics (median, 6 antibiotic groups). Infections occurred on amean of 41.5 days after admission. The mean length of stay after infection was 54.6 daysand 5 (23.8%) patients died due to the infection. Treatment was mainly based on acolistin-containing regimen (47.6%) or tigecycline (33.3%). Although clinical anddemographic characteristics were similar between the two groups, all 7 patients treatedwith tigecycline had total resolution of the infection and a significantly shorter length ofhospital stay after infection.Conclusions: patients who suffered an infection by a PDR gram-negative organism werecharacterized by severe underlying diseases, significant comorbidity, long hospital stayand previous exposure to multiple antimicrobials and invasive devices. The prolongationof hospitalization after PDR infection was notable, but mortality was not as high asexpected. Administration of tigecycline was associated with successful treatment anddecreased length of hospital stay. Prudent use of tigecycline is needed to preserve it as anoption for successful treatment of infections caused by PDR microrganisms.Study 3: Evolution of multidrug resistance in Klebsiella pneumoniae isolates in hospitals of CreteBackground: KPC-2-producing Klebsiella pneumoniae sequence type (ST)-258 has beenrapidly expanding and is often associated with serious infectious carrying a high mortality,necessitating the use of last-line antibiotics including colistin and tigecycline.Objective: To describe the genetic determinants of acquired resistance in carbapenem-resistant K. pneumoniae isolates and to assess the evolution of resistance through time, inhospitals of Crete.Methods: Randomly selected, single-patient carbapenem-resistant K. pneumoniae strainsrecovered during 2 periods, 2010 and 2013/14, in three hospitals of Crete (UniversityHospital of Heraklion, Venizelio General Hospital and General Hospital Rethymnon) werecollected and analyzed. Phenotypic, molecular and whole genome analysis wereperformed, in order to define the molecular mechanisms of acquired resistance.Furthermore, resistance patterns between the 2 time periods were compared.Results: Among 34 collected strains (11 in 2010 and 23 in 2013/14), six were panresistantin 2013/14. All KPC-KP isolates produced the KPC-2 carbapenemase which is consideredendemic in Greece. All isolates but one belonged to ST258. Notable higher resistance ratesto colistin and tigecycline were detected in 2013/14 compared to 2010. Resistance tocolistin is associated with mutations in mgrB, while resistance to tigecycline is associatedto ramR or to absence of the RamRA operon. A high diversity of multiple resistance genesthat were detected, indicate complex transmission dynamics.Conclusions: This study reports the genetic determinants of antibiotic resistance to betalactam and non-beta-lactam antibiotics among clinical isolates of K. pneumoniae fromhospitals of Crete. Molecular resistance mechanisms as well as the emergence of panresistantstrains are described. Comparison between 2 time periods showed that theoutbreak strain evolves and disseminates rapidly. In addition, core genome-MLST isshown as a promising tool for molecular fingerprinting of KPC-KP ST258. Interventionsare needed to withstand further transmission of this phenotype, which holds graveimplications for the healthcare system.Study 4: Application of international guidelines for the control of a nosocomial outbreak: The example of an outbreak due to pandrug resistant Acinetobacter baumanniiBackground: The emergence and spread of pandrug-resistant (PDR) pathogens in hospitalsis of great concern, with severe potential consequences for the healthcare system andpatient outcomes.Objective: This study reports the effectiveness of a bundle of interventions applied for themanagement of an outbreak due to PDR A. baumannii (PDR-AB) in a tertiary-care hospitalin Crete. The microbiological, molecular and clinical characteristics of the epidemic strainare also described.Methods: The outbreak evolved in 3 phases from February through October 2014,according to applied interventions. Molecular and genomic analysis of the outbreak strainswas performed, and clinical characteristics of patients were retrospectively retrieved. AsPDR-AB spread continued despite initial measures, a bundle of interventions according toESCMID recommendations was applied. These included enhanced hand hygiene, patientisolation, environmental and patient screening cultures, chlorhexidine bathing, alert codes,pre-emptive contact precautions in the ICU, continuous staff education, thoroughenvironmental cleaning, and structural modifications.Results: PDR-AB was identified in 39 patients, of which 22 were in the ICU. Rep-PCRanalysis revealed that the outbreak was due to clonal dissemination. Full genomesequencing revealed the antimicrobial resistance gene content. Carbapenem-resistancewas correlated with an intrinsic blaOXA-66 copy and the acquired blaOXA-23 gene. Theoutbreak was contained only after implementation of the extensive bundle ofinterventions. Mortality among the PDR-AB infected patients was 57.1%.Conclusions: This study illustrates that only the application of an extensive bundle ofmeasures according to international recommendations enabled containment of the PDRABoutbreak.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsioutis, Constantinos
  • Τσιούτης, Κωνσταντίνος

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/37001

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsioutis, Constantinos; Τσιούτης, Κωνσταντίνος. Κλινικοεπιδημιολογική μελέτη και έλεγχος της πολυαντοχής των βακτηριδίων στο Πανεπιστημιακό Γενικό Νοσοκομείο Ηρακλείου. University of Crete (UOC), 2016. http://hdl.handle.net/10442/hedi/37001